BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 25201756)

  • 1. Rictor/mammalian target of rapamycin 2 regulates the development of Notch1 induced murine T-cell acute lymphoblastic leukemia via forkhead box O3.
    Hua C; Guo H; Bu J; Zhou M; Cheng H; He F; Wang J; Wang X; Zhang Y; Wang Q; Zhou J; Cheng T; Xu M; Yuan W
    Exp Hematol; 2014 Dec; 42(12):1031-40.e1-4. PubMed ID: 25201756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors.
    Lee D; Sykes SM; Kalaitzidis D; Lane AA; Kfoury Y; Raaijmakers MH; Wang YH; Armstrong SA; Scadden DT
    Stem Cell Reports; 2014 Nov; 3(5):832-40. PubMed ID: 25418727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia.
    Lee K; Nam KT; Cho SH; Gudapati P; Hwang Y; Park DS; Potter R; Chen J; Volanakis E; Boothby M
    J Exp Med; 2012 Apr; 209(4):713-28. PubMed ID: 22473959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1.
    Guertin DA; Stevens DM; Thoreen CC; Burds AA; Kalaany NY; Moffat J; Brown M; Fitzgerald KJ; Sabatini DM
    Dev Cell; 2006 Dec; 11(6):859-71. PubMed ID: 17141160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rictor has a pivotal role in maintaining quiescence as well as stemness of leukemia stem cells in MLL-driven leukemia.
    Fang Y; Yang Y; Hua C; Xu S; Zhou M; Guo H; Wang N; Zhao X; Huang L; Yu F; Cheng H; Wang ML; Meng L; Cheng T; Yuan W; Ma D; Zhou J
    Leukemia; 2017 Feb; 31(2):414-422. PubMed ID: 27499138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1).
    García-Martínez JM; Alessi DR
    Biochem J; 2008 Dec; 416(3):375-85. PubMed ID: 18925875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity.
    Jacinto E; Facchinetti V; Liu D; Soto N; Wei S; Jung SY; Huang Q; Qin J; Su B
    Cell; 2006 Oct; 127(1):125-37. PubMed ID: 16962653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.
    Martelli AM; Evangelisti C; Chappell W; Abrams SL; Bäsecke J; Stivala F; Donia M; Fagone P; Nicoletti F; Libra M; Ruvolo V; Ruvolo P; Kempf CR; Steelman LS; McCubrey JA
    Leukemia; 2011 Jul; 25(7):1064-79. PubMed ID: 21436840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperactivation of mTORC1 and mTORC2 by multiple oncogenic events causes addiction to eIF4E-dependent mRNA translation in T-cell leukemia.
    Schwarzer A; Holtmann H; Brugman M; Meyer J; Schauerte C; Zuber J; Steinemann D; Schlegelberger B; Li Z; Baum C
    Oncogene; 2015 Jul; 34(27):3593-604. PubMed ID: 25241901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of mTOR complex 1 induces developmental blockage in early T-lymphopoiesis and eradicates T-cell acute lymphoblastic leukemia cells.
    Hoshii T; Kasada A; Hatakeyama T; Ohtani M; Tadokoro Y; Naka K; Ikenoue T; Ikawa T; Kawamoto H; Fehling HJ; Araki K; Yamamura K; Matsuda S; Hirao A
    Proc Natl Acad Sci U S A; 2014 Mar; 111(10):3805-10. PubMed ID: 24567410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rictor/mammalian target of rapamycin complex 2 promotes macrophage activation and kidney fibrosis.
    Ren J; Li J; Feng Y; Shu B; Gui Y; Wei W; He W; Yang J; Dai C
    J Pathol; 2017 Aug; 242(4):488-499. PubMed ID: 28585302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac mTOR complex 2 preserves ventricular function in pressure-overload hypertrophy.
    Shende P; Xu L; Morandi C; Pentassuglia L; Heim P; Lebboukh S; Berthonneche C; Pedrazzini T; Kaufmann BA; Hall MN; Rüegg MA; Brink M
    Cardiovasc Res; 2016 Jan; 109(1):103-14. PubMed ID: 26598511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rictor in perivascular adipose tissue controls vascular function by regulating inflammatory molecule expression.
    Bhattacharya I; Drägert K; Albert V; Contassot E; Damjanovic M; Hagiwara A; Zimmerli L; Humar R; Hall MN; Battegay EJ; Haas E
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2105-11. PubMed ID: 23868942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rictor/mTORC2 signaling mediates TGFβ1-induced fibroblast activation and kidney fibrosis.
    Li J; Ren J; Liu X; Jiang L; He W; Yuan W; Yang J; Dai C
    Kidney Int; 2015 Sep; 88(3):515-27. PubMed ID: 25970154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR.
    Yin Y; Hua H; Li M; Liu S; Kong Q; Shao T; Wang J; Luo Y; Wang Q; Luo T; Jiang Y
    Cell Res; 2016 Jan; 26(1):46-65. PubMed ID: 26584640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IKK interacts with rictor and regulates mTORC2.
    Xu Y; Lai E; Liu J; Lin J; Yang C; Jia C; Li Y; Bai X; Li M
    Cell Signal; 2013 Nov; 25(11):2239-45. PubMed ID: 23872070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian target of rapamycin complex 2 regulates invariant NKT cell development and function independent of promyelocytic leukemia zinc-finger.
    Prevot N; Pyaram K; Bischoff E; Sen JM; Powell JD; Chang CH
    J Immunol; 2015 Jan; 194(1):223-30. PubMed ID: 25404366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian Target of Rapamycin Complex 2 Controls CD8 T Cell Memory Differentiation in a Foxo1-Dependent Manner.
    Zhang L; Tschumi BO; Lopez-Mejia IC; Oberle SG; Meyer M; Samson G; Rüegg MA; Hall MN; Fajas L; Zehn D; Mach JP; Donda A; Romero P
    Cell Rep; 2016 Feb; 14(5):1206-1217. PubMed ID: 26804903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rictor/mTORC2 protects against cisplatin-induced tubular cell death and acute kidney injury.
    Li J; Xu Z; Jiang L; Mao J; Zeng Z; Fang L; He W; Yuan W; Yang J; Dai C
    Kidney Int; 2014 Jul; 86(1):86-102. PubMed ID: 24451322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.